371
On 19.09.2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 470. The active ingredient is Човешки хетероложни чернодробни клетки за инфузия for treatment of ornithine-transcarbamylase deficiency.